Table 5.
Lipid contents (% of wet weight) and fatty acid compositions (% of total fatty acids) of liver and muscle from juvenile Atlantic bluefin tuna (Thunnus thynnus L.) fed either a reference diet (Magokoro®), 15% lipid diet based on krill oil (15KO), or 20% lipid diet based on krill oil (20KO) in trial A
| Liver | Muscle | |||||
|---|---|---|---|---|---|---|
| MGK | 15KO | 20KO | MGK | 15KO | 20KO | |
| Total lipid (%) | 6.5 ± 0.8a | 3.4 ± 0.7b | 2.2 ± 0.1c | 0.8 ± 0.2 | 0.8 ± 0.1 | 0.8 ± 0.0 |
| 14:0 | 2.5 ± 0.1a | 1.6 ± 0.3b | 0.5 ± 0.1c | 0.8 ± 0.1a | 0.7 ± 0.1a | 0.3 ± 0.0b |
| 16:0 | 18.0 ± 0.7c | 20.6 ± 0.2b | 24.7 ± 1.0a | 19.6 ± 0.2a | 20.5 ± 1.9a | 17.3 ± 0.8b |
| 18:0 | 6.3 ± 0.2b | 6.8 ± 0.1b | 11.4 ± 0.5a | 10.9 ± 0.3b | 10.5 ± 0.4b | 14.1 ± 0.4a |
| Total SFA1 | 28.2 ± 1.1b | 30.1 ± 0.2b | 38.8 ± 1.0a | 33.1 ± 1.1 | 33.6 ± 1.9 | 34.3 ± 0.7 |
| 16:1n−7 | 3.7 ± 0.2a | 2.6 ± 0.2b | 1.1 ± 0.1c | 1.3 ± 0.2a | 1.2 ± 0.2a | 0.7 ± 0.1b |
| 18:1n−9 | 15.6 ± 0.7a | 9.6 ± 0.3b | 5.8 ± 1.3c | 9.0 ± 0.4a | 8.0 ± 0.1b | 7.8 ± 0.6b |
| 18:1n−7 | 4.1 ± 0.2a | 4.5 ± 0.1a | 3.0 ± 0.3b | 3.0 ± 0.2b | 3.8 ± 0.1a | 3.7 ± 0.1a |
| 20:1n−9 | 2.0 ± 0.1a | 1.2 ± 0.1b | 0.3 ± 0.0c | 0.7 ± 0.1a | 0.9 ± 0.1a | 0.5 ± 0.0b |
| Total MUFA2 | 30.0 ± 1.2a | 19.8 ± 0.3b | 12.1 ± 2.2c | 17.8 ± 0.4a | 15.0 ± 0.1b | 13.7 ± 0.4b |
| 18:2n−6 | 6.9 ± 0.3a | 1.8 ± 0.2b | 0.9 ± 0.1c | 3.3 ± 0.1a | 1.4 ± 0.1b | 1.3 ± 0.1b |
| 20:4n−6 | 1.7 ± 0.1b | 1.3 ± 0.1c | 2.4 ± 0.1a | 2.0 ± 0.1a | 1.2 ± 0.1c | 1.6 ± 0.1b |
| 22:5n−6 | 0.7 ± 0.1 | 0.9 ± 0.1 | 1.1 ± 0.1 | 1.6 ± 0.1a | 1.0 ± 0.1b | 1.2 ± 0.2b |
| Total n−6 PUFA3 | 11.3 ± 0.4a | 5.7 ± 0.3c | 6.8 ± 0.6b | 8.2 ± 0.1a | 5.6 ± 0.3c | 6.6 ± 0.1b |
| 18:3n-3 | 0.8 ± 0.1a | 0.5 ± 0.0b | 0.2 ± 0.0c | 0.3 ± 0.0a | 0.3 ± 0.0a | 0.2 ± 0.0b |
| 18:4n−3 | 0.9 ± 0.1a | 0.6 ± 0.2a | 0.3 ± 0.0b | 0.3 ± 0.0a | 0.3 ± 0.0a | 0.2 ± 0.0b |
| 20:4n−3 | 0.5 ± 0.0a | 0.3 ± 0.0b | 0.2 ± 0.0b | 0.3 ± 0.0a | 0.2 ± 0.0b | 0.2 ± 0.0b |
| 20:5n−3 | 6.1 ± 0.4b | 7.8 ± 0.7a | 5.7 ± 0.4b | 5.3 ± 0.2c | 7.6 ± 0.3a | 6.5 ± 0.2b |
| 22:5n−3 | 2.1 ± 0.2a | 2.1 ± 0.2a | 0.8 ± 0.0b | 1.6 ± 0.1a | 1.5 ± 0.2ab | 1.2 ± 0.0b |
| 22:6n−3 | 15.1 ± 1.3b | 27.0 ± 0.8a | 28.8 ± 0.9a | 28.3 ± 0.3b | 31.9 ± 0.8a | 31.2 ± 0.5a |
| Total n−3 PUFA4 | 27.1 ± 2.0b | 39.6 ± 0.2a | 37.5 ± 1.3a | 37.6 ± 0.2b | 42.7 ± 2.2a | 40.7 ± 1.8a |
| C16 PUFA | 2.4 ± 0.1a | 1.7 ± 0.0b | 2.6 ± 0.1a | 2.0 ± 0.1a | 2.0 ± 0.0b | 2.4 ± 0.1a |
| Total PUFA | 38.4 ± 2.3b | 45.4 ± 0.4a | 44.4 ± 1.8a | 45.8 ± 1.3 | 48.3 ± 2.4 | 47.3 ± 1.9 |
| DHA/EPA | 2.5 ± 0.1c | 3.5 ± 0.4b | 5.1 ± 0.2a | 5.3 ± 0.1a | 4.2 ± 0.1c | 4.8 ± 0.1b |
| n−3/n−6 | 2.4 ± 0.1c | 6.9 ± 0.3a | 5.5 ± 0.3b | 4.6 ± 0.2c | 7.6 ± 0.2a | 6.2 ± 0.3b |
| Unknown | 3.4 ± 0.3b | 4.7 ± 0.2a | 4.7 ± 0.4a | 3.3 ± 0.2ab | 3.1 ± 0.2b | 4.7 ± 0.3a |
Results are means ± SD (n = 2). An SD of 0.0 implies an SD of < 0.05. Mean values, within the same dietary trial, bearing different superscript letters are significantly different (P < 0.05). 1Totals include 15:0, 20:0, 22:0, and 24:0. 2Totals include 16:1n−9, 18:1n−11, 20:1n−7, 22:1 isomers, and 24:1. 3Totals include 18:3n−6, 20:2n−6, and 22:4n−6. 4Totals include 20:3n−3 and 22:3n−3
DHA docosahexaenoic acid, EPA eicosapentaenoic acid, MGK Magokoro, MUFA monounsaturated fatty acid, PUFA polyunsaturated fatty acid, SFA saturated fatty acid, 15KO diet containing 15% lipid as krill oil, 20KO diet containing 20% lipid as krill oil, 15KORO diet containing 15% lipid as 50% krill oil and 50% rapeseed oil